Zhengye Biotechnology Holding Limited Gains 35.54%
Mon, Apr 28, 2025 at 07:50 PM
Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ) rocketted at $14.15, a gain of 35.5%. On Mon, Apr 28, 2025, ZYBT:NASDAQ touched a New 2-Week High of $14.15. The stock appeared on our News Catalysts scanner on Mon, Apr 07, 2025 at 09:12 AM in the 'BIOTECH' category. From Mon, Apr 14, 2025, the stock recorded 66.67% Up Days and 80.00% Green Days
About Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ)
Zhengye Biotechnology Holding, through its operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock.
Top 10 Gainers:
- Movella Holdings Inc Com (MVLA:NASDAQ), 861.54%
- AGM Group Holdings Inc. (AGMH:NASDAQ), 175.72%
- LogicMark Inc Com Par$ (New) (LGMK:NASDAQ), 48.28%
- Pony AI Inc. (PONY:NASDAQ), 47.22%
- Universe Pharmaceuticals Inc (UPC:NASDAQ), 40.33%
- JIADE LIMITED (JDZG:NASDAQ), 36.57%
- Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ), 35.54%
- Aardvark Therapeutics Inc. (AARD:NASDAQ), 27.62%
- Portage Biotech Inc. (PRTG:NASDAQ), 27.46%
- Wag! Group Co. (PET:NASDAQ), 26.69%